Hence, preventing PD-1 interactions with its ligands PD-L1 and PD-L2 in the tumor microenvironment is expected to restore the cytotoxic functions of exhausted tumor-specific T cells and has achieved significant success in the management of advanced stage solid tumors. The gene discussed is CD274; the disease is neoplasm.